Literature DB >> 21309772

Annual Research Review: Transgenic mouse models of childhood-onset psychiatric disorders.

Holly R Robertson1, Guoping Feng.   

Abstract

Childhood-onset psychiatric disorders, such as attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), mood disorders, obsessive compulsive spectrum disorders (OCSD), and schizophrenia (SZ), affect many school-age children, leading to a lower quality of life, including difficulties in school and personal relationships that persist into adulthood. Currently, the causes of these psychiatric disorders are poorly understood, resulting in difficulty diagnosing affected children, and insufficient treatment options. Family and twin studies implicate a genetic contribution for ADHD, ASD, mood disorders, OCSD, and SZ. Identification of candidate genes and chromosomal regions associated with a particular disorder provide targets for directed research, and understanding how these genes influence the disease state will provide valuable insights for improving the diagnosis and treatment of children with psychiatric disorders. Transgenic mouse models are one important approach in the study of human diseases, allowing for the use of a variety of experimental approaches to dissect the contribution of a specific chromosomal or genetic abnormality in human disorders. While it is impossible to model an entire psychiatric disorder in a single mouse model, these models can be extremely valuable in dissecting out the specific role of a gene, pathway, neuron subtype, or brain region in a particular abnormal behavior. In this review we discuss existing transgenic mouse models for childhood-onset psychiatric disorders. We compare the strength and weakness of various transgenic mouse models proposed for each of the common childhood-onset psychiatric disorders, and discuss future directions for the study of these disorders using cutting-edge genetic tools.
© 2011 The Authors. Journal of Child Psychology and Psychiatry © 2011 Association for Child and Adolescent Mental Health.

Entities:  

Mesh:

Year:  2011        PMID: 21309772      PMCID: PMC3075087          DOI: 10.1111/j.1469-7610.2011.02380.x

Source DB:  PubMed          Journal:  J Child Psychol Psychiatry        ISSN: 0021-9630            Impact factor:   8.982


  392 in total

1.  Mildly impaired water maze performance in male Fmr1 knockout mice.

Authors:  R D'Hooge; G Nagels; F Franck; C E Bakker; E Reyniers; K Storm; R F Kooy; B A Oostra; P J Willems; P P De Deyn
Journal:  Neuroscience       Date:  1997-01       Impact factor: 3.590

2.  Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse.

Authors:  Yann S Mineur; Frans Sluyter; Sanne de Wit; Ben A Oostra; Wim E Crusio
Journal:  Hippocampus       Date:  2002       Impact factor: 3.899

Review 3.  Events governing organization of postmigratory neurons: studies on brain development in normal and reeler mice.

Authors:  A M Goffinet
Journal:  Brain Res       Date:  1984-08       Impact factor: 3.252

4.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

Authors:  Elena D Nosyreva; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2006-02-01       Impact factor: 2.714

5.  Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.

Authors:  Gary E Duncan; Sheryl S Moy; Jeffrey A Lieberman; Beverly H Koller
Journal:  Pharmacol Biochem Behav       Date:  2006-11-13       Impact factor: 3.533

6.  Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome.

Authors:  Caitlyn H McNaughton; Jisook Moon; Myla S Strawderman; Kenneth N Maclean; Jeffrey Evans; Barbara J Strupp
Journal:  Behav Neurosci       Date:  2008-04       Impact factor: 1.912

Review 7.  Children with obsessive-compulsive disorder: are they just "little adults"?

Authors:  Simran K Kalra; Susan E Swedo
Journal:  J Clin Invest       Date:  2009-04-01       Impact factor: 14.808

8.  Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium.

Authors:  Sevag A Kaladchibachi; Brad Doble; Norman Anthopoulos; James R Woodgett; Armen S Manoukian
Journal:  J Circadian Rhythms       Date:  2007-02-12

9.  Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice.

Authors:  Sergey V Shmelkov; Adília Hormigo; Deqiang Jing; Catia C Proenca; Kevin G Bath; Till Milde; Evgeny Shmelkov; Jared S Kushner; Muhamed Baljevic; Iva Dincheva; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; George D Yancopoulos; Ipe Ninan; Francis S Lee; Shahin Rafii
Journal:  Nat Med       Date:  2010-04-25       Impact factor: 53.440

10.  Mania-like behavior induced by disruption of CLOCK.

Authors:  Kole Roybal; David Theobold; Ami Graham; Jennifer A DiNieri; Scott J Russo; Vaishnav Krishnan; Sumana Chakravarty; Joseph Peevey; Nathan Oehrlein; Shari Birnbaum; Martha H Vitaterna; Paul Orsulak; Joseph S Takahashi; Eric J Nestler; William A Carlezon; Colleen A McClung
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-22       Impact factor: 11.205

View more
  13 in total

1.  Severe cross-modal object recognition deficits in rats treated sub-chronically with NMDA receptor antagonists are reversed by systemic nicotine: implications for abnormal multisensory integration in schizophrenia.

Authors:  Derek L Jacklin; Amit Goel; Kyle J Clementino; Alexander W M Hall; John C Talpos; Boyer D Winters
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

Review 2.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

Review 3.  Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

Authors:  Kun-Yong Kim; Yong Wook Jung; Gareth J Sullivan; Leeyup Chung; In-Hyun Park
Journal:  Trends Mol Med       Date:  2012-07-06       Impact factor: 11.951

Review 4.  iPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls.

Authors:  Daria Prilutsky; Nathan P Palmer; Niklas Smedemark-Margulies; Thorsten M Schlaeger; David M Margulies; Isaac S Kohane
Journal:  Trends Mol Med       Date:  2013-12-24       Impact factor: 11.951

5.  Expression of Nampt in hippocampal and cortical excitatory neurons is critical for cognitive function.

Authors:  Liana Roberts Stein; David F Wozniak; Joshua T Dearborn; Shunsuke Kubota; Rajendra S Apte; Yukitoshi Izumi; Charles F Zorumski; Shin-ichiro Imai
Journal:  J Neurosci       Date:  2014-04-23       Impact factor: 6.167

Review 6.  Genetic evidence for role of integration of fast and slow neurotransmission in schizophrenia.

Authors:  A Devor; O A Andreassen; Y Wang; T Mäki-Marttunen; O B Smeland; C-C Fan; A J Schork; D Holland; W K Thompson; A Witoelar; C-H Chen; R S Desikan; L K McEvoy; S Djurovic; P Greengard; P Svenningsson; G T Einevoll; A M Dale
Journal:  Mol Psychiatry       Date:  2017-03-28       Impact factor: 15.992

7.  Autistic-like syndrome in mu opioid receptor null mice is relieved by facilitated mGluR4 activity.

Authors:  Jérôme A J Becker; Daniel Clesse; Coralie Spiegelhalter; Yannick Schwab; Julie Le Merrer; Brigitte L Kieffer
Journal:  Neuropsychopharmacology       Date:  2014-03-12       Impact factor: 7.853

8.  Genetic effects on cerebellar structure across mouse models of autism using a magnetic resonance imaging atlas.

Authors:  Patrick E Steadman; Jacob Ellegood; Kamila U Szulc; Daniel H Turnbull; Alexandra L Joyner; R Mark Henkelman; Jason P Lerch
Journal:  Autism Res       Date:  2013-10-22       Impact factor: 5.216

9.  Oxidation of polychlorinated biphenyls by liver tissue slices from phenobarbital-pretreated mice is congener-specific and atropselective.

Authors:  Xianai Wu; Michael Duffel; Hans-Joachim Lehmler
Journal:  Chem Res Toxicol       Date:  2013-10-23       Impact factor: 3.739

Review 10.  Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish.

Authors:  Jasmine M McCammon; Hazel Sive
Journal:  Dis Model Mech       Date:  2015-07-01       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.